Retraction: Small interfering RNA-induced inhibition of epithelial Cell transforming sequence 2 suppresses the proliferation, migration and invasion of osteosarcoma cells (Experimental and Therapeutic Medicine (2015) 9 (1881-1886) DOI: 10.3892/etm.2015.2306);Small interfering RNA-induced inhibition of epithelial cell transforming sequence 2 suppresses the proliferation, migration and invasion of osteosarcoma cells

Experimental and Therapeutic Medicine

Volumn 9, Issue 5, 2015, Pages 1881-1886

  Xie, Jie ^a   Lei, Pengfei ^a   Hu, Yihe ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Epithelial cell transforming sequence 2; Invasion; Osteosarcoma; Proliferation

Indexed keywords

MATRIX METALLOPROTEINASE; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL ONCOGENE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL CELL TRANSFORMING SEQUENCE 2 ONCOGENE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MTT ASSAY; OSTEOSARCOMA; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SURVIVAL RATE; TRANSWELL ASSAY; WESTERN BLOTTING;

EID: 84925071459     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2021.10408     Document Type: Erratum

References (22)

1. PosthumaDeBoer J, Witlox MA, Kaspers GJ and van Royen BJ: Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature. Clin Exp Metastasis 28: 493-503, 2011.
2. Liang W, Gao B, Fu P, Xu S, Qian Y and Fu Q: The miRNAs in the pathogenesis of osteosarcoma. Front Biosci (Landmark Ed) 18: 788-794, 2013.
3. Tatsumoto T, Xie X, Blumenthal R, Okamoto I and Miki T: Human ECT2 is an exchange factor for rho GTpases, phosphorylated in G2/M phases and involved in cytokinesis. J Cell Biol 147: 921-928, 1999.
4. Salhia B, Tran NL, Chan A, et al: The guanine nucleotide exchange factors trio, Ect2 and Vav3 mediate the invasive behavior of glioblastoma. Am J Pathol 173: 1828-1838, 2008.
5. Miki T, Smith CL, Long JE, Eva A and Fleming TP: Oncogene ect2 is related to regulators of small GTP-binding proteins. Nature 362: 462-465, 1993.
6. Fields AP and Justilien V: The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancer. Adv Enzyme Regul 50: 190-200, 2010.
7. Murata Y, Minami Y, Iwakawa R, et al: ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma. Cancer Sci 105: 490-497, 2014.
8. Xu J, Yao Q, Hou Y, et al: MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation. Biomed Pharmacother 67: 381-386, 2013.
9. Zhang H, Yin Z, Ning K, Wang L, Guo R and Ji Z: Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma. Hum Pathol 45: 1430-1436, 2014.
10. Yang YL, Chu JY, Luo ML, et al: Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma. Genes Chromosomes Cancer 47: 127-136, 2008.
11. Hussenet T, Dali S, Exinger J, et al: SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One 5: e8960, 2010.
12. Wang Y, Hill KS and Fields AP: PKCiota maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis. Mol Cancer Res 11: 1624-1635, 2013.
13. Nalini V, Segu R, Deepa PR, Khetan V, Vasudevan M and Krishnakumar S: Molecular insights on post-chemotherapy retinoblastoma by microarray gene expression analysis. Bioinform Biol Insights 7: 289-306, 2013.
14. Samuel N, Sayad A, Wilson G, et al: Integrated genomic, transcriptomic and RNA-interference analysis of genes in somatic copy number gains in pancreatic ductal adenocarcinoma. Pancreas 42: 1016-1026, 2013.
15. Vazquez-Mena O, Medina-Martinez I, Juarez-Torres E, et al: Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines. PLoS One 7: e32667, 2012.
16. Jung Y, Lee S, Choi HS, et al: Clinical validation of colorectal cancer biomarkers identified from bioinformatics analysis of public expression data. Clin Cancer Res 17: 700-709, 2011.
17. Iyoda M, Kasamatsu A, Ishigami T, et al: Epithelial cell transforming sequence 2 in human oral cancer. PLoS One 5: e14082, 2010.
18. Etienne-Manneville S and Hall A: Rho GTPases in cell biology. Nature 420: 629-635, 2002.
19. Boettner B and Van Aelst L: The role of Rho GTPases in disease development. Gene 286: 155-174, 2002.
20. Fortin SP, Ennis MJ, Schumacher CA, et al: Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells. Mol Cancer Res 10: 958-968, 2012.
21. Sano M, Genkai N, Yajima N, et al: Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. Oncol Rep 16: 1093-1098, 2006.
22. Justilien V, Jameison L, Der CJ, Rossman KL and Fields AP: Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation. J Biol Chem 286: 8149-8157, 2011.